Hypotension and reduced catecholamines in neuropeptide Y transgenic rats

Hypertension

Volumn 41, Issue 5, 2003, Pages 1056-1062

  Michalkiewicz, Mieczyslaw ^a   Knestaut, Kriss M ^b   Bytchkova, Elena Yu ^b   Michalkiewicz, Teresa ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE

Author keywords

Catecholamines; Hypotension; Nervous system, sympathetic renal; Rats, transgenic; Stress; Sympatholytics

Indexed keywords

CATECHOLAMINE; NEUROPEPTIDE Y;

ADRENERGIC ACTIVITY; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ANXIETY; ARTICLE; BLOOD PRESSURE REGULATION; CATECHOLAMINE RELEASE; CONTROLLED STUDY; FORCED SWIMMING TEST; GANGLION BLOCK; HEART PROTECTION; HYPOTENSION; LONGEVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOENZYMATIC ASSAY; RAT; STRESS; TELEMETRY; TRANSGENIC ANIMAL; WATER IMMERSION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOOD PRESSURE; BRAIN; CATECHOLAMINES; FEMALE; GENOTYPE; HEART RATE; HYPOTENSION; MALE; NEUROPEPTIDE Y; RATS; RATS, SPRAGUE-DAWLEY; STRESS; SURVIVAL ANALYSIS; SWIMMING;

EID: 0038334619     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000066623.64368.4E     Document Type: Article

References (43)

1. Dumont Y, Martel JC, Fournier A, St-Pierre S, Quirion R. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog Neurobiol. 1992;38:125-167.
2. Glass MJ, Chan J, Pickel VM. Ultrastructural localization of neuropeptide Y Y1 receptors in the rat medial nucleus tractus solitarius: relationships with neuropeptide Y or catecholamine neurons. J Neurosci Res. 2002;67:753-765.
3. Stornetta RL, Akey PJ, Guyenet PG. Location and electrophysiological characterization of rostral medullary adrenergic neurons that contain neuropeptide Y mRNA in rat medulla. J Comp Neurol. 1999;415:482-500.
4. Minson JB, Llewellyn-Smith IJ, Pilowsky PM, Chalmers JP. Bulbospinal neuropeptide Y-immunoreactive neurons in the rat: comparison with adrenaline-synthesising neurons. J Auton Nerv Syst. 1994;47:233-243.
5. Tseng CJ, Lin HC, Wang SD, Tung CS. Immunohistochemical study of catecholamine enzymes and neuropeptide Y in the rostral ventrolateral medulla and bulbospinal projection. J Comp Neurol. 1993;334:294-303.
6. Zukowska-Grojec Z, Wahlestedt C. Origin and actions of NPY in the cardiovascular system. In: Colmers WF, Wahlestedt C, eds. The Biology of Neuropeptide Y and Related Peptides. Clifton, NJ: Humana Press; 1993:315-389.
7. Fried G, Terenius L, Dockray G, Fahrenkro S, Goldstein M, Hoklell T. Neuropeptide Y and noradrenaline coexist in sympathetic neurons innervating the bovine spleen. Cell Tissue Res. 1986;243:495-508.
8. Lundberg JM, Fried G, Pernow J, Theodorsson-Norheim E. Co-release of neuropeptide Y and catecholamines upon adrenal activation in the cat. Acta Physiol Scand. 1986;126:231-238.
9. Egawa M, Yoshimatsu H, Bray GA. Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. Am J Physiol. 1991;260:R328-R334.
10. Matsumura K, Tsuchihashi T, Abe I. Central cardiovascular action of neuropeptide Y in conscious rabbits. Hypertension. 2000;36:1040-1044.
11. Tseng CJ, Mosqueda-Garcia R, Appalsamy M, Robertson D. Cardiovascular effects of neuropeptide Y in rat brainstem nuclei. Circ Res. 1989; 64:55-61.
12. McAuley MA, Macrae IM, Reid JL. The cardiovascular actions of clonidine and neuropeptide-Y in the ventrolateral medulla of the rat. Br J Pharmacol. 1989;97:1067-1074.
13. Wahlestedt C, Pich EM, Koob GF, Yee F, Heilig M. Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science. 1993;259:528-531.
14. Michalkiewicz M, Michalkiewicz T. Developing transgenic neuropeptide Y rats. In: Balasubramaniam A, ed. Methods in Molecular Biology: Neuropeptide Y Protocols. Totowa, NJ: Humana Press; 2000:73-89.
15. Thorsell A, Michalkiewicz M, Dumont Y, Quirion R, Caberlotto L, Rimondini R, Mathé A, Heilig M. Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in NPY transgenic rats. Proc Natl Acad Sci U S A. 2000;97:12852-12857.
16. Michalkiewicz M, Michalkiewicz T, Kreulen D, McDougall S. Increased vascular responses in neuropeptide Y transgenic rats. Am J Physiol. 2001;281:R417-R426.
17. Vezzani A, Michalkiewicz M, Michalkiewicz T, Moneta D, Ravizza T, Richichi C, Aliprandi M, Mulé F, Gobbi M, Schwarzer C, Sperk G. Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y. Neuroscience. 2002;110:237-243.
18. Ferrari AU, Daffonchio S, Albergati F, Bertoli P, Mancia G. Intra-arterial pressure alterations during tail-cuff blood pressure measurements in normotensive and hypertensive rats. J Hypertens. 1990;8:909-911.
19. Zukowska-Grojec Z, Shen GH, Capraro PA, Vaz CA. Cardiovascular, neuropeptide Y, and adrenergic responses in stress are sexually differentiated. Physiol Behav. 1991;49:771-777.
20. Garcia-Lecumberri C, Ambrosio E. Differential effect of low doses of intracerebroventricular corticotropin-releasing factor in forced swimming test. Pharmacol Biochem Behav. 2000;67:519-525.
21. Michalkiewicz M, Dey M, Huffman LJ, Hedge GA. The neuropeptides, VIP and NPY, that are present in the thyroid nerves are not released into the thyroid vein. Thyroid. 1998;8:1073-1079.
22. Michalkiewicz M, Huffman LJ, Hedge GA. Endogenous neuropeptide Y regulates thyroid blood flow. Am J Physiol. 1993;264:E699-E705.
23. Schreihofer AM, Stornetta RL, Guyenet PG. Regulation of sympathetic tone and arterial pressure by rostral ventrolateral medulla after depletion of C1 cells in rat. Physiology. 2000;529:221-236.
24. Tsuda K, Tsuda S, Masuyama Y, Goldstein M. Norepinephrine release and neuropeptide Y in medulla oblongata of spontaneously hypertensive rats. Hypertension. 1990;15:784-790.
25. Klapstein GJ, Colmers WF. On the sites of presynaptic inhibition by neuropeptide Y in rat hippocampus in vitro. Hippocampus. 1993;3:103-111.
26. Bacci A, Huguenard JR, Prince DA. Differential modulation of synaptic transmission by neuropeptide Y in rat neocortical neurons. Proc Natl Acad Sci USA. 2002;99:17125-17130.
27. Westfall TC, Carpentier S, Chen X, Beinfeld MC, Naes L, Meldrum MJ. Prejunctional and postjunctional effects of neuropeptide Y at the noradrenergic neuroeffector junction of the perfused mesenteric arterial bed of the rat. J Cardiovasc Pharmacol. 1987;10:716-722.
28. Lundberg JM, Pernow J, Tatemoto K, Dahlof C. Pre- and postjunctional effects of NPY on sympathetic control of rat femoral artery. Acta Physiol Scand. 1985;123:511-513.
29. Malmstrom RE, Lundberg JN, Weitzberg E. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo. Naunyn Schmiedebergs Arch Pharmacol. 2002;365:106-111.
30. Kask A, Harro J, von Horsten S, Redrobe JP, Dumont Y, Quirion R. The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev. 2002;26:259-283.
31. Correia ML, Morgan DA, Sivitz WI, Mark AL, Haynes WG. Hemodynamic consequences of neuropeptide Y-induced obesity. Am J Hypertens. 2002;15:137-142.
32. Minson RB, McRitchie RJ, Chalmers JP. Effects of neuropeptide Y on baroreflex control of heart rate and myocardial contractility in conscious rabbits. Clin Exp Pharmacol Physiol. 1990;17:39-49.
33. Fontes MA, Tagawa T, Polson JW, Cavanagh SJ, Dampney RA. Descending pathways mediating cardiovascular response from dorsomedial hypothalamic nucleus. Am J Physiol. 2001;280:H2891-H2901.
34. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev. 1990;70:963-985.
35. Pierdomenico SD, Bucci A, Costantini F, Lapenna D, Cuccurullo F, Mezzetti A. Twenty-four-hour autonomic nervous function in sustained and "white coat" hypertension. Am Heart J. 2000;140:672-677.
36. Hansell P, Isaksson B, Sjoquist M, Sjoquist M. Renal dopamine and noradrenaline excretion during CNS-induced natriuresis in spontaneously hypertensive rats: influence of dietary sodium. Acta Physiol Scand. 2000; 168:257-266.
37. Rahmouni K, Haynes WG. Leptin signaling pathways in the central nervous system: interactions between neuropeptide Y and melanocortins. Bioessays. 2001;23:1095-1099.
38. Erickson JC, Clegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 1996;381:415-421.
39. Marsh DJ, Hollopeter G, Kafer KE, Palmiter RD. Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat Med. 1998;4:718-721.
40. Julius S, Valentini M. Consequences of the increased autonomic nervous drive in hypertension, heart failure and diabetes. Blood Press. 1998;(suppl 3):5-13.
41. Mancia G, Cattaneo BM, Grassi G. Clinical benefits of a consistent reduction in blood pressure. J Hypertens Suppl. 1998;16:S35-S39.
42. Westfall TC, Han SP, Knuepfer M, Martin J, Chen X, Del Valle K, Naes L. Neuropeptides in hypertension: role of neuropeptide Y and calcitonin gene related peptide. Br J Clin Pharmacol. 1990;30:75S-82S.
43. Gross AJ, Clark VA. Survival Distributions. New York, NY: Wiley; 1975.